Public Health and Social Services Emergency Fund
Schedules
TAFS: 075-0140 /X - Public Health and Social Services Emergency Fund
| Line # | Split | Description | Amount | Footnotes |
|---|---|---|---|---|
| 1000 | DE | Discretionary Estimated Unob Bal: Brought forward, Oct 1 | $11,972,871,322.00 | |
| 1000 | ME | Mandatory Estimated Unob Bal: Brought forward, Oct 1 | $16,485,616,041.00 | |
| 1920 | Total budgetary resources avail (disc. and mand.) | $28,458,487,363.00 | ||
| 6001 | Category A -- 1st quarter | $17,242.00 | ||
| 6013 | Strategic National Stockpile | $389,123,997.00 | ||
| 6015 | Pandemic Influenza (Vaccines, Antivirals & Diagnostics) | $17,692,690.00 | ||
| 6016 | Pandemic Influenza (Facilities, Vaccines, Antivirals, and Diagnostics) | $450,942.00 | ||
| 6017 | Pandemic Influenza (Other HHS Activities) | $6,407,549.00 | ||
| 6018 | Pandemic Influenza (Other CDC Activities) | $1,846,318.00 | ||
| 6019 | Parklawn Lease Replacement | $846,677.00 | ||
| 6021 | Haiti CDC | $3,104,362.00 | ||
| 6024 | HHS Lease Replacements | $1,207,894.00 | ||
| 6025 | Project BioShield | $758,642,301.00 | ||
| 6026 | Pandemic Influenza | $211,664,463.00 | ||
| 6027 | NDMS | $69,927.00 | ||
| 6028 | Bioterrorism | $409,222.00 | ||
| 6029 | CDC Capacity | $306,206.00 | ||
| 6030 | Natural Disasters | $4,888,792.00 | ||
| 6032 | CDC Preparedness | $175,229.00 | ||
| 6035 | Pediatric Activities | $5,078.00 | ||
| 6037 | Coronavirus 2 Testing for the Uninsured | $968,233.00 | ||
| 6038 | Coronavirus 3 Healthcare Provider Reimbursements | $191,753,205.00 | ||
| 6039 | Coronavirus 4 Healthcare Provider Reimbursements | $10,056,730,235.00 | ||
| 6040 | Coronavirus 4 Allocations to State, Local, Tribal and other entities | $223,663,590.00 | ||
| 6041 | Coronavirus 4 BARDA | $5,986,951.00 | ||
| 6042 | Coronavirus 4 Testing for Uninsured | $3,434.00 | ||
| 6043 | Coronavirus 4 Rural Health Clinics Testing | $20,998,223.00 | ||
| 6044 | Coronavirus 4 HHS Response Activities | $75,908,562.00 | ||
| 6047 | Coronavirus 6 Healthcare Provider Reimbursements | $478,097,940.00 | ||
| 6048 | Coronavirus 6 Testing, Contact Tracing, and Mitigation Activities | $10,634,915,114.00 | ||
| 6049 | Coronavirus 6 Public Health Workforce | $3,918,118,293.00 | ||
| 6050 | Coronavirus 6 Strategic National Stockpile | $850,000,000.00 | ||
| 6051 | Coronavirus 6 Antivirals | $396,770,377.00 | ||
| 6052 | Coronavirus 6 Vaccines, Therapeutics, and Medical Supplies | $130,214,317.00 | ||
| 6053 | Coronavirus 6 Medical Reserve Corps | $77,500,000.00 | ||
| 6190 | Total budgetary resources available | $28,458,487,363.00 |
Footnotes
Footnotes provide further information about, or establish further legal requirements related to the use of, the funds in a given line or set of lines in an apportionment. If footnotes appear on lines 1920 or 6190, they apply to all the lines in the 1xxx and 6xxx sections, respectively. The following are all the footnotes associated with this file.
No footnotes available.
Notes about this page
- † Links to public laws are automatically generated and are not guaranteed to be accurate.